Having problems reading this email or accessing the links?
To view this email in your web browser, click
here.
To change your preferred email format or unsubscribe, click
here.
|
|||||||||||||||||||||||||||||||
Scientists Find Key to Gene That Promotes Cancer MetastasisIn This Issue: LEAD
WHAT'S NEW AT ZERO
RESEARCH AND TREATMENT UPDATE
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
LeadScientists Find Key to Gene That Promotes Cancer MetastasisThe molecular machinery that activates the RhoA gene to cause cancer to spread has now been identified, and this discovery opens the door to developing drugs that can suppress this gene's activity. New Method to Study Key Targets in Alzheimer's Disease and Prostate CancerBy mapping difficult-to-define proteins like those in Alzheimer's disease and prostate cancer, researchers hope for clues that can lead to new drugs designed to stop tumor growth. Gen. Powell Discusses Prostate Cancer on Facebook
"Men should have regular prostate examinations," Gen. Colin Powell advises his 22,700 Facebook followers. "Regular exams allowed me to deal with this problem early and make a full recovery." |
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
What's New at ZEROCapitol Hill Briefing on Prostate Cancer Set for April 20The Prostate Cancer Foundation, in conjunction with ZERO - The Project to End Prostate Cancer, is hosting a Capitol Hill briefing entitled "Reaching Beyond the PSA Debate: Identifying New Biomarkers So We Can Overtreat Less and Cure More." The event will look beyond the current PSA testing debate in order to examine current and future research that may lead to new breakthroughs in testing, diagnosis and therapies for the disease.
Confirmed participants at the briefing include:
Funding for Prostate Cancer Research at Risk - Write Congress Today!Please WRITE TODAY to Support the Prostate Cancer Research Program
The Prostate Cancer Research Program is one of the Congressionally Directed Medical Research Programs at the Department of Defense. For more than 10 years, the program has been the model of efficiency and effectiveness, but now after nine years of nearly stagnant funding, the program is being forced to make tough funding decisions -- which could jeopardize good research and prolong our fight against the disease that takes the lives of 27,000 men each year. Please write to your Congressman and Senators today. Ask them to support the request made by their colleagues to provide increased funding for the Prostate Cancer Research Program. For every year that Congress does not increase this funding, more research is left on the review table and less work is done to move research into critical clinical trials that could save lives. Register for the 2010 'Summit to End Prostate Cancer' in Washington, D.C.
You can make a positive impact this Fall by representing ZERO and the entire prostate cancer community in Washington, D.C. Registration for the 2010 "Summit to End Prostate Cancer" is now open! This 2010 Summit, scheduled for September 14-16, will focus on effective strategies for increasing the Federal investment in prostate cancer research. During the Summit, participants will have the opportunity to meet with their elected officials on Capitol Hill and learn more about the federal legislative process. Join the Drive Against Prostate Cancer by Supporting 'Pennies for Prostates'Now is your chance to take command, sit in the driver's seat, and put the 'pedal to the metal' to show your support for the prostate cancer community. That's what Robin Sparrow plans to do this April, driving his BMW more than 3,000 miles in 12 days as part of the One Lap of America Race - the "real life" Cannonball Run. Be a Star Athlete -- Register Now to Join ZERO's DASH FOR DAD Team
Help fight prostate cancer by joining ZERO's DASH FOR DAD Endurance Team! Even though the teams are now complete for the Nautica New York City Triathlon and the Bank of America Chicago Marathon, you still have time to sign up to be among the runners on the DASH FOR DAD Endurance Team at the Marine Corps Marathon in Washington, D.C. on October 24, or the ING New York City Marathon on November 7. These race slots go quickly, so please sign up soon! For more information, contact Tracy Cesaretti at 202-303-3111. ZERO - The Project to End Prostate Cancer provides you with fundraising advice and support, your own donation website and list-serv, and other tools to make your participation in these races highly memorable and successful. Every dollar raised goes toward free prostate cancer testing for men across the U.S. 'DASH FOR DAD' Race Series Coming to 11 Cities to Raise Prostate Cancer AwarenessAs National Race Series Expands Across U.S. in 2010, Supporters Are Encouraged to Bring This Event to Their City Lace up your sneakers and join us in the race to end prostate cancer! DASH FOR DAD, the premier prostate cancer race series in the U.S., is a heartfelt tight-knit community event that brings together athletes, cancer survivors, physicians, caregivers, family members and friends. Proceeds from each 10K race are used to provide free prostate cancer testing for men in the local community of the event. ZERO - The Project to End Prostate Cancer, with sponsors from across the country, has grown the DASH FOR DAD and its partner races - the Great Prostate Cancer Challenge - to include 11 cities and an expected 7,000 runners competing in 2010. The DASH FOR DAD or partnering Great Prostate Cancer Challenge 5K will be held in the following cities:
Since the national race series began in 2008, more than $1 million has been raised to promote prostate cancer awareness, early detection and research. Many runners create teams and collect monetary pledges from family and friends to boost funding for local prostate cancer services. Hosting a DASH FOR DAD is a significant way to promote prostate cancer awareness in your area - and there is still time to bring this race to your city! Urology medical practices and other supporting organizations are especially encouraged to organize a DASH FOR DAD, due to the importance of providing free prostate cancer testing and promoting research for a cure. Click here to download the DASH FOR DAD race application. "DASH FOR DAD elevates prostate cancer awareness to a broader nationwide level," said ZERO's CEO Skip Lockwood. "We all know someone who is impacted by this most commonly diagnosed cancer among men, striking one in every six. That's why we must do all that we can to put an end to this horrible disease." For more information about the DASH FOR DAD 10K or if you're interested in hosting a DASH FOR DAD run to your city, contact Tracy Cesaretti. Health Care Reform Meeting in NYC on April 24
Congressman Ed Towns is hosting an informative meeting entitled "Health Care and You" on April 24 in New York City. This event will focus on the health care reform bill as well as a timeline for the implementation of the new legislation. Time and location:
For more information, please contact Roberta Hopkins or Peter Williams at (202) 225-5936. Massachusetts Prostate Cancer Symposium Coming May 8The 13th Annual Massachusetts Prostate Cancer Symposium, scheduled May 8 in Quincy, offers a variety of informative panel discussions and workshops on the latest in prostate cancer treatment, research and social issues. This event, open to the public at no charge, is sponsored by the Massachusetts Prostate Cancer Coalition and other organizations. |
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Research and Treatment UpdateNew Agent Chokes Off Energy Supply, Kills Cancer CellsAn experimental drug has been developed by Ohio researchers that causes cancer cells to self-destruct, as this "energy restriction" process deprives cancer cells of their main energy source, the sugar glucose. Gamma-Tocotrienol Kills Prostate Tumour Cells in Animal Model StudiesGamma-tocotrienol, a member of the vitamin E family, is potent in killing prostate cells, and tumour shrinkage was achieved when used in conjunction with the chemotherapy treatment Docetaxel. CytRx to Initiate a Phase 2 Clinical Trial With Bafetinib in Advanced Prostate CancerA new clinical trial is planned for up to 50 patients with metastatic hormone-refractory prostate cancer, and researchers hope bafetinib can provide a better quality of life by reducing drug-related side effects. Prostate Cancer Surgery More Costly for Obese MenMedical costs for obese patients are found to be higher for both traditional and "keyhole" types of surgical care, but not for robot-assisted laparoscopic surgery. |
|||||||||||||||||||||||||||||||
ClassifiedsAdvertise in AWARE, ZERO's weekly electronic newsletter, to reach more than 20,000 readers throughout the prostate cancer community in the U.S. and abroad. Contact Jamie Bearse at (202) 303-3105 to learn more about our advertising and partner development opportunities. |
||
![]() |
![]() |
|
![]() |
![]() |
|
Brand New! Your PSA score may be 22 percent higher than actual score. There are two different standardizations of PSA tests and the difference in score could mean you have an undetected rising PSA or a false rise in the score. Know the facts, get this DVD about PSA standardization. Prostate Cancer Action Store Show your support for the fight against prostate cancer and purchase the latest items, including educational materials and apparel, in ZERO's online store. |
||
Subscription Info You received
this newsletter because your email address ( Forward to a Friend: To Subscribe: To
Edit Your Profile or Unsubscribe: |
Advertising Info Reach thousands with America's largest online newsletter all about prostate cancer. To Advertise, Contact: Contact Info ZERO - The Project to End Prostate Cancer Director of Communications: Creative Director: Chief Operating Officer: AWARE is managed in-house by ZERO's communications department. |
|
AWARE is America's premier online, weekly newsletter that brings you information about prostate cancer. It is produced by ZERO - The Project to End Prostate Cancer (ZERO). This publication seeks to inform and educate men and women about prostate cancer. Information presented in this free publication does not necessarily represent the official position of ZERO. As information for AWARE is brought to you from diverse websites and information sources, ZERO cannot guarantee the accuracy of these sources. Due to the timeliness of the information, some links may change or deactivate without notice. Copyright © 2009 ZERO - The Project to End Prostate Cancer. All Rights Reserved. ZERO does not endorse any course of treatment for men with prostate cancer or other conditions. Treatment decisions should be made by a patient and his health service provider. All names, logos and articles are the copyrights of the respective owners. |
|